Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164658 · ClinicalTrials.gov registry record · Phase 1
Evaluating Tools for Health Promotion and Disease Prevention
A Phase 1 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 8,400
- Enrollment target
NCT00164658: Completed Phase 1 study, sponsored by Centers for Disease Control and Prevention.
NCT00164658 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 8,400 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13900% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164658, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8,400 participants
- Enrollment target
Study Summary
The study will evaluate the effect of familial risk assessment and prevention prompts tailored to familial risk on health behaviors and use of preventive services among adults who are members of primary care practices in the U.S.
Interventions
- BEHAVIORAL Familial risk assessment and personalized prevention messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,400 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00164658 record still lists
NCT00164658 is an interventional study that assigns participants to a tested intervention. Its 8,400 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13900% higher).
The record links to 0 conditions, and to 1 intervention - of which Familial risk assessment and personalized prevention messages is the first listed.
NCT00164658 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00164658 about?
NCT00164658 is a clinical study titled "Evaluating Tools for Health Promotion and Disease Prevention". The study will evaluate the effect of familial risk assessment and prevention prompts tailored to familial risk on health behaviors and use of preventive services among adults who are members of primary care practices in the U.S.
What is the current status of trial NCT00164658?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8,400 participants. The study started on 2005-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00164658?
The interventions under investigation include: Familial risk assessment and personalized prevention messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164658?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00164658's enrollment target sits among peer trials
8,400 1st of 2000 higher than 2,000 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia